MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 94 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,861,000 | +56.2% | 1,519,888 | +24.8% | 0.00% | – |
| Q1 2020 | $2,472,000 | +25.0% | 1,217,647 | +33.0% | 0.00% | – |
| Q4 2019 | $1,978,000 | +37.9% | 915,859 | -1.7% | 0.00% | – |
| Q3 2019 | $1,434,000 | -61.1% | 931,433 | +4.9% | 0.00% | – |
| Q2 2019 | $3,685,000 | +23.7% | 888,008 | +24.7% | 0.00% | – |
| Q1 2019 | $2,978,000 | +75.3% | 712,325 | +20.3% | 0.00% | – |
| Q4 2018 | $1,699,000 | -70.8% | 592,067 | +1.8% | 0.00% | – |
| Q3 2018 | $5,817,000 | +49.4% | 581,696 | +5.6% | 0.00% | – |
| Q2 2018 | $3,893,000 | +2333.1% | 550,774 | +1210.8% | 0.00% | – |
| Q1 2018 | $160,000 | -42.7% | 42,019 | +22.6% | 0.00% | – |
| Q4 2017 | $279,000 | +18.7% | 34,277 | -14.5% | 0.00% | – |
| Q3 2017 | $235,000 | – | 40,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $2,440,000 | 0.40% |
| ArrowMark Colorado Holdings LLC | 942,059 | $1,715,000 | 0.03% |
| A.R.T. Advisors, LLC | 39,100 | $71,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 52,432 | $95,000 | 0.02% |
| Orbimed Advisors | 567,600 | $1,033,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 15,697 | $29,000 | 0.01% |
| Palo Alto Investors LP | 63,517 | $116,000 | 0.01% |
| Virtu KCG Holdings LLC | 90,063 | $164,000 | 0.00% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $18,000 | 0.00% |
| FRANKLIN RESOURCES INC | 2,182,185 | $3,972,000 | 0.00% |